Når Hexavac i de kliniske studier blev co- administreret, var antallet af febrile reaktioner imidlertid højere end ved administration af hexavalente vacciner alene.
However, when HEXAVAC was co-administered in clinical studies the rate of febrile reactions was higher compared to that occurring following administration of hexavalent vaccines alone.